Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
PDB-H4112 | Human | Human PDGF-BB Protein, Tag Free | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
PDB-H5127 | Human | Unconjugated Human PDGF-BB Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
KUR-212 | KUR-212; I-020502 | Phase 2 Clinical | Kuros Biosciences | Burns | Details |
HL-217 | HL-217; KR-31831 | Phase 1 Clinical | Korea Research Institute Of Chemical Technology (Krict) | Macular Degeneration | Details |
SHP-627 | FT-11; FT-001; FT-011; SHP-627 | Phase 2 Clinical | Shire Pharmaceuticals | Scleroderma, Systemic; Glaucoma; Scleroderma, Diffuse | Details |
This web search service is supported by Google Inc.